NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/26/2026
Back to search
Official data from USPTO
CELLTOLERANCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELLTOLERANCE
ST13
US500000079408132Class
42, 44
Filing
79408132
Registration
8268362
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/26/2026
Trademark type
Word
Nice classes
42, 44
Filing date
07/22/2024
Registration date
05/26/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2026
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
FR
Examiner
BLAKESLEE, RICHARD A
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
M. T. (pessoa física)
Representatives
Jeff Goehring Nixon & Vanderhye P.C.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological servicesscientific research and design services in the field of diagnostic tools for medical applications; Development of new technology on behalf of third parties in the field of biotechnology; providing information relating to medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; scientific research and development in the field of pharmaceuticals and biotechnology; analyzingassessing and reporting diagnostic test results and diagnostic or prognostic tests of residual disease to assist healthcare professionals in the clinical diagnosis of a patientto assess the effectiveness of treatments prescribed to patients and change future treatments accordingly; medical and scientific research in the field of treatment and diagnosis of digestive and gastrointestinal diseases and disorders
Class 44
Health care services for human beingsnamely gastrointestinal health care services; medical analysis services relating to the treatment of patients; medical services for the remote analysis of optical samples and diagnosis on cells; medical services relating to the collectiontreatment and processing of human cells; medical assessment of health status for medical diagnostic purposes; medical diagnosis servicesmedical diagnosis of digestive disorders; medical diagnostic and testing services in relation to digestive and gastrointestinal diseases and disorders; medical testing services for diagnostic or treatment purposes; health care management in the nature of developing care protocols in relation to digestive and gastrointestinal diseases and disorders; providing news and information in the field of medicine; provision of information relating to medical services; provision of medical information in the field of health; providing medical information in the field of gastroenterology; individual medical advisory services provided to patients; medical testing services for the diagnosis and treatment of persons
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/16/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2026
PUBO
PUBLISHED FOR OPPOSITION
04/07/2026
GPNX
NOTIFICATION PROCESSED BY IB
04/02/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/30/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/29/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/18/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/18/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/22/2025
GNFR
FINAL REFUSAL E-MAILED
08/22/2025
CNFR
FINAL REFUSAL WRITTEN
08/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/19/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/19/2025
RFNT
REFUSAL PROCESSED BY IB
03/22/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/04/2025
RFRR
REFUSAL PROCESSED BY MPU
03/04/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/16/2025
CNRT
NON-FINAL ACTION WRITTEN
01/15/2025
DOCK
ASSIGNED TO EXAMINER
01/08/2025
MAFR
APPLICATION FILING RECEIPT MAILED
11/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/01/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/31/2024
Continuous trademark protection
Get notified about every new filing that threatens CELLTOLERANCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.